Explore FHI 360

Publication

USAID Healthy Behaviors Activity Literature Review

This literature review focuses on the facilitators of and barriers to priority behaviors for the USAID Healthy Behaviors Activity.

Tools

Counseling Script for Contraceptive Injectables for Family Planning Providers

This evidence-based script, developed in Malawi, is for facility- and community-based family planning providers to counsel family planning clients on injectable contraception.

Published research

Removal of a well-palpable one-rod subdermal contraceptive implant using a dedicated hand-held device or standard technique: A randomized, open-label, non-inferiority trial

Project

USAID Healthy Behaviors Activity

The USAID Healthy Behaviors Activity seeks to increase sustained adoption of healthy behaviors in Ethiopia using evidence-based, theory-informed social and behavior change strategies.

Feature

Adaptive management improves and enables effective social and behavior change programming

FHI 360 uses an adaptive management approach to improve integrated social and behavior change programming in Tanzania through the USAID Tulonge Afya project.

Publication

Uganda Communication for Healthy Communities Project: Accomplishments and Lessons Learned

Briefs highlight accomplishments and lessons learning from the Communication for Healthy Communities project in Uganda, funded by the U.S. Agency for International Development.

Event

International Conference on Family Planning: #NextGenFP and FHI 360

At the 2018 International Conference on Family Planning, FHI 360 shares results from our latest research, programs, innovative interventions and digital technologies.

Published research

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial

The authors found that women who self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) led to a more than 50 percent increase in pregnancy protection through 12 months compared with provider-administered injection. The findings demonstrate that self-injection can address the stubborn problem of early contraceptive discontinuation and that community health workers can safely train women to self-inject. Malawi plans to introduce DMPA-SC self-injection based on these positive findings.

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

USAID Healthy Behaviors Activity Literature Review

Counseling Script for Contraceptive Injectables for Family Planning Providers

Removal of a well-palpable one-rod subdermal contraceptive implant using a dedicated hand-held device or standard technique: A randomized, open-label, non-inferiority trial

USAID Healthy Behaviors Activity

Adaptive management improves and enables effective social and behavior change programming

Uganda Communication for Healthy Communities Project: Accomplishments and Lessons Learned

International Conference on Family Planning: #NextGenFP and FHI 360

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Search within these results

8 Results Found

USAID Healthy Behaviors Activity Literature Review

Counseling Script for Contraceptive Injectables for Family Planning Providers

Removal of a well-palpable one-rod subdermal contraceptive implant using a dedicated hand-held device or standard technique: A randomized, open-label, non-inferiority trial

USAID Healthy Behaviors Activity

Adaptive management improves and enables effective social and behavior change programming

Uganda Communication for Healthy Communities Project: Accomplishments and Lessons Learned

International Conference on Family Planning: #NextGenFP and FHI 360

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial